Unlocking the Immune Shield: How Breastfeeding Protects Against Breast Cancer
Originally published: 2025-10-26
Breast cancer remains one of the most prevalent cancers worldwide, affecting millions of women each year. For decades, researchers have known that breastfeeding offers protective benefits against this disease, but the “why” behind it has been a mystery, until now. A recent study sheds light on how lactation triggers a surge in specialized immune cells that act as vigilant sentinels in breast tissue, potentially warding off cancer for decades.
The Long-Standing Link Between Breastfeeding and Cancer Risk
It’s no secret that motherhood comes with health perks. Previous research has shown that breastfeeding can reduce a woman’s risk of developing breast cancer by about 4.3% for every year of lactation, with even stronger effects for older mothers. But pregnancy itself has a nuanced relationship with cancer: it only lowers risk if it happens at a younger age, while later pregnancies might slightly increase it. What makes breastfeeding the key differentiator? Enter the immune system.
“These cells act like local guards, ready to attack abnormal cells that might turn into cancer.”
— Sherene Loi, lead researcher at Peter MacCallum Cancer Centre
Discovering the Cellular Protectors: CD8+ T Cells
At the heart of this protection are CD8+ T cells, a type of specialized immune cell that “remembers” threats and stands ready to eliminate them. The study found that women who have breastfed exhibit significantly higher levels of these cells in their breast tissue compared to those who haven’t. These aren’t fleeting visitors, they can persist for up to 50 years after childbirth, creating a long-term defense mechanism.
In mouse models, researchers simulated the full cycle of pregnancy, lactation, and post-weaning recovery (known as involution). Only mice that completed this entire process showed a substantial buildup of CD8+ T cells in their mammary glands. When aggressive triple-negative breast cancer cells were implanted, tumors grew much slower in these lactation-experienced mice, thanks to the enhanced immune infiltration. Depleting the CD8+ T cells reversed this effect, allowing rapid tumor growth and confirming their pivotal role.
The mechanism? During breastfeeding, these T cells likely flood the breasts to prevent infections like mastitis, then stick around as tissue-resident memory cells (TRM-like), providing ongoing surveillance against cancerous changes.
Real-World Evidence: From Lab to Clinic
The findings aren’t just theoretical. Analyzing breast tissue from 260 women (aged 20–70, diverse ethnic backgrounds, varying parity and breastfeeding histories, but no prior cancer), the team confirmed higher CD8+ T cell accumulation in those who had breastfed. Extending this to over 1,000 women diagnosed with triple-negative breast cancer (an aggressive subtype) after at least one full-term pregnancy, those with a breastfeeding history had tumors denser in CD8+ T cells and enjoyed longer overall survival rates, even after adjusting for factors like age.
“This suggests there was ongoing immune activation and regulation from the body against their breast cancer.”
— Sherene Loi
Notably, the protection seems systemic: lactation changes the body’s overall immunity, not just in the breasts. This could extend benefits to other cancers or diseases, though more research is needed.
Implications for Women’s Health and Beyond
This discovery, published in Nature on October 20, 2025, reinforces the recommendations for breastfeeding while highlighting its role beyond infant nutrition. It could pave the way for new prevention strategies, like therapies that mimic these immune boosts for women who can’t or choose not to breastfeed. As Loi notes, understanding these cells’ “memory” of breastfeeding could lead to tailored treatments for aggressive cancers.
“I’m hopeful that this type of research will lead to new approaches to reduce women’s breast cancer risk.”
— Wendy Ingman, breast health researcher at University of Adelaide Medical School
Limitations and Future Directions
While promising, the study has caveats. The human data is observational, making causation harder to prove, and the variability in breastfeeding duration prevented clear conclusions on “how much” is optimal. It focused primarily on triple-negative breast cancer, leaving questions about hormone-sensitive types. Researchers emphasize that breastfeeding is a personal choice, not always feasible, and doesn’t guarantee cancer prevention.
Future work might explore how to harness these CD8+ T cells therapeutically, as suggested by experts like Nicholas Huntington: “What this study enables us to do is get a better understanding of the immune cell types... that might be more important to target with emerging therapies.”
Wrapping Up: A Call to Celebrate and Investigate
Breastfeeding’s benefits just got a powerful new endorsement from science. By arming the body with enduring immune guardians, it offers a natural shield against one of women’s greatest health threats. As we continue to unravel these mechanisms, let’s support informed choices and research that empowers all women in their health journeys.
